Final Exam Flashcards
safe to give live vacc if CD4 is
> 200 for HIV pts
tetanus and diptheria
booster every 10 years
TDAP
safe in pregnancy, protect baby from whooping cough
MMR
obtain titers, give in 2 doses if no immunity
varicella
2 doses given 4-8 wks apart
hep A and B
combo given in 3 doses at birth
1-2 mos and 406 mos
MMR and varicella
live vaccines
not safe during pregnancy
HPV
dead virus
give males and females starting age 13
colon cancer screening
age 45 if no fam hx then every 10 years
mammogram
yearly age 45-54
pap smear
for cervical ca every 3 years starting age 25
-every 5 years for HPV
when to test for TB
risk factors- travel, immigration, congregate living
positive TB
5-15mm sometimes, >15mm always positive
latent TB
skin test or quantiferon, will have neg cxray
-impaired immunity pts have higher risk of developing active TB from latent
HLD screening
cholesterol every 5 years starting age 20
Ezetimibe
lowers LDL
Niacin
lowers TG, s/e headache and flushing, used for TG >250
secondary causes of HLD
CKD, obesity, tobacco, alc
BMI
25-29 overweight, >30 obese
DM screening
annual aged 45 and older
-higher risk if belly >40 inches
eye exam
2-4 years
most preventable cause of disease in US
tobacco
diagnosis of asthma
FEV1 <80% of predicted or FEV1/FVC <65%
Asthma tx
- ICS, LABA, LAMA
- leukotriene modifiers
- biologics only for severe disease
monitor asthma pt
1-2 mos after starting then every 3-12 mos
-within 1 wk exacerbation
pregnant asthmatics
monitor every 4-6 weeks
reversible airway obstruction
12% increase in FEV1 post- SABA tx
S/s pna
crackels, bronchial breath sounds, tactile fremitis, egophony, tachycardic
low risk pna
can be treated outpt
tx PNA
amoxicillin, doxy, macrolide
tx PNA with comorbidities
augmentin, cephalosporin/macrolide, doxy, or fluroquinolone
sarcoidosis
systemic disease affecting lungs in most cases
sarcoidosis s/s
fever, neuropathy, myopathy, blood dyscrasias, hypercalcemia
sarcoidsis cxray
bilateral hilar and right paratracheal lymph adenopathy
tx sarcoidosis
steroids or immunosuppressants
risk factor COPD
tobacco smoke, MJ, pollution, coal miners
s/s COPD
SOB, chronic cough, sputum, hx risk factors
diagnosis COPD
FEV1/FVC <0.7 after bronchodilator
COPD pts should be screened for
Alpha 1 antitrypsin
COPD tx
- SABA, LABA
- antimuscarinics- SAMA, LAMA
- ICS
- phosphodiesterase inhibitors
- methylxantines
- oral steroids
CAD risk factors
HTN, HLD, smoking, obesity, DM, stress
systolic CHF
< 40% EF
diastolic CHF
> 40% EF
CHF risk factors
metabolic syndrome, doxorubicin, fam hx cardiomyopathy
stage A CHF
high risk but no structural dx or s/s
ACEi or ARB, statin when indicated
stage b chf
structural dx without signs of HF
ACEi, ARB, BB
stage c CHF
structural dx with current or prior HF
Treat comorbidities, diuresis, revascularization
Diuretics, hydralazine, isosorbide dinitrate, digoxin
Some need ICD, CRT, valve surg
stage D CHF
refractory, symptoms at risk, always in hospital
LVAD, transplant, chronic inotropes, palliative, hospice, turn off ICD
CHF classes
o Class I: no limitations
o Class II: slight limitation of physical activity, no sx at rest
o Class III: Marked limitation of physical activity
o Class IV: Inability to carry on any physical activity without discomfort
chronic HF tx
Diuretics, ACE, ARB, aldosterone antagonist, BB
in selected pts
• Vasodilators- nitrates, BiDi
• Positive inotrope-Digoxin-monitor K+ levels
• Ivabradine (Corlanor)- not for ADHF or with bradycardia
• Sacubitril/valsartan (Entresto
left sided HF
backup into atria and pulm veins, pulm congestion and edema
right sided HF
backs into R atria and venous circulation- JVD, hepatomegaly, vascular congestion and peripheral edema
Main cause is RV infarct or PE, chronic pulm HTN
A-fib cHADs- stroke risk score
CHF history HTN hx Age >75 DM hx Stroke or TIA symptoms previously
diabetes dx
A1C of 6.5 or higher
o FBG >126
o Oral tolerance test >200
prediabetes dx
o Impaired fasting glucose 100-125
o A1C 5.7-6.4%
dysmetabolic syndrome
impaired fasting glucose, elevated triglycerides, low HDL, central obesity, inc BMI, HTN
LADA
latent autoimmune diabetes in adults, eventually requires insulin, usually non-obese
o Insulin resistance (inc BMI)
Biguanides, thizaolidinediones